JP4335002B2 - 生分解性多価アルコールエステル - Google Patents

生分解性多価アルコールエステル Download PDF

Info

Publication number
JP4335002B2
JP4335002B2 JP2003516444A JP2003516444A JP4335002B2 JP 4335002 B2 JP4335002 B2 JP 4335002B2 JP 2003516444 A JP2003516444 A JP 2003516444A JP 2003516444 A JP2003516444 A JP 2003516444A JP 4335002 B2 JP4335002 B2 JP 4335002B2
Authority
JP
Japan
Prior art keywords
polyhydric alcohol
caprolactone
biodegradable
ppcl
pgcl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003516444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536929A5 (enExample
JP2004536929A (ja
Inventor
ラン・メイドン
チ−チャン・チュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of JP2004536929A publication Critical patent/JP2004536929A/ja
Publication of JP2004536929A5 publication Critical patent/JP2004536929A5/ja
Application granted granted Critical
Publication of JP4335002B2 publication Critical patent/JP4335002B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • C08G63/08Lactones or lactides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/042Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
JP2003516444A 2001-08-02 2002-07-15 生分解性多価アルコールエステル Expired - Fee Related JP4335002B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30918001P 2001-08-02 2001-08-02
PCT/US2002/019816 WO2003011212A2 (en) 2001-08-02 2002-07-15 Biodegradable polyhydric alcohol esters

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009064455A Division JP2009167418A (ja) 2001-08-02 2009-03-17 生分解性多価アルコールエステル

Publications (3)

Publication Number Publication Date
JP2004536929A JP2004536929A (ja) 2004-12-09
JP2004536929A5 JP2004536929A5 (enExample) 2006-01-05
JP4335002B2 true JP4335002B2 (ja) 2009-09-30

Family

ID=23197041

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003516444A Expired - Fee Related JP4335002B2 (ja) 2001-08-02 2002-07-15 生分解性多価アルコールエステル
JP2009064455A Pending JP2009167418A (ja) 2001-08-02 2009-03-17 生分解性多価アルコールエステル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009064455A Pending JP2009167418A (ja) 2001-08-02 2009-03-17 生分解性多価アルコールエステル

Country Status (6)

Country Link
US (1) US6592895B2 (enExample)
EP (1) EP1411903A4 (enExample)
JP (2) JP4335002B2 (enExample)
AU (1) AU2002316340B2 (enExample)
CA (1) CA2450123C (enExample)
WO (1) WO2003011212A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1168934T3 (da) * 1999-04-12 2008-05-13 Cornell Res Foundation Inc Hydrogeldannende system med hydrofobe og hydrofile komponenter
US6716445B2 (en) 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
US7229979B2 (en) 2003-06-23 2007-06-12 Immune Modulation, Inc. Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
KR100578737B1 (ko) * 2003-06-25 2006-05-12 학교법인 포항공과대학교 반응성 방사구조 고분자 및 이를 이용한 저유전성 고분자복합체 박막
JP2005046611A (ja) * 2003-07-01 2005-02-24 Medtronic Vascular Inc 薬剤含有ポリマーが塗布されたステント用のエネルギーで活性化された接着剤層
US7169404B2 (en) * 2003-07-30 2007-01-30 Advanced Cardiovasular Systems, Inc. Biologically absorbable coatings for implantable devices and methods for fabricating the same
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
US7670616B2 (en) * 2004-03-11 2010-03-02 Cornell Research Foundation, Inc. Hydrogel forming system comprising PEG derivative precursor
CA2560507C (en) 2004-03-26 2011-08-16 Surmodics, Inc. Composition and method for preparing biocompatible surfaces
ATE442822T1 (de) * 2004-04-02 2009-10-15 Arterial Remodelling Technolog Stentanordnung auf polymerbasis
US20050220853A1 (en) * 2004-04-02 2005-10-06 Kinh-Luan Dao Controlled delivery of therapeutic agents from medical articles
US8246993B2 (en) * 2004-06-10 2012-08-21 Cytogel Pharma, Llc Advantageous hydrogel composition
US20060013886A1 (en) * 2004-06-28 2006-01-19 Daqing Wu Injectable microspheres
CA2570734A1 (en) * 2004-06-28 2006-02-02 Cornell Research Foundation, Inc. Injectable microspheres from unsaturated functionalized polyhydric alcohol esters
FI122108B (fi) * 2004-11-17 2011-08-31 Jvs Polymers Oy Silloittuva biopolymeeri
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
CA2630661A1 (en) * 2005-11-29 2007-06-07 Indiana University Research And Technology Corporation Biodegradable implant ploymers and composites
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
EP2076211A4 (en) * 2006-10-20 2015-07-22 Elixir Medical Corp LUMINOUS PROSTHESES AND METHODS OF COATING THEREOF
MX2010010663A (es) 2008-03-28 2010-11-09 Surmodics Inc Dispositivos medicos insertables que tienen substratos elasticos asociados con microparticulas, y metodos de suministro de farmacos.
CN106913902A (zh) 2009-11-09 2017-07-04 聚光灯技术合伙有限责任公司 多糖基水凝胶
EP2498764B1 (en) 2009-11-09 2017-09-06 Spotlight Technology Partners LLC Fragmented hydrogels
EP3090755A1 (en) 2010-05-21 2016-11-09 Cytogel Pharma, LLC Materials and methods for treatment of inflammation
EP3081937B1 (en) 2011-07-18 2019-11-13 President and Fellows of Harvard College Engineered microbe-targeting molecules and uses thereof
US9988617B2 (en) 2013-05-21 2018-06-05 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
WO2015095604A2 (en) 2013-12-18 2015-06-25 President And Fellows Of Harvard College Methods and assays relating to circulating tumor cells
CN106232106B (zh) 2014-04-18 2020-08-11 奥本大学 用于诱导先天性和适应性免疫力的颗粒状疫苗制剂
US10293044B2 (en) 2014-04-18 2019-05-21 Auburn University Particulate formulations for improving feed conversion rate in a subject
US10519443B2 (en) 2014-09-08 2019-12-31 University Of Iowa Research Foundation Microrna inhibitor system and methods of use thereof
WO2016100520A1 (en) * 2014-12-16 2016-06-23 Boston Scientific Scimed, Inc. Bioerodible polymer compositions
WO2017024114A1 (en) 2015-08-06 2017-02-09 President And Fellows Of Harvard College Improved microbe-binding molecules and uses thereof
US10583199B2 (en) 2016-04-26 2020-03-10 Northwestern University Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
US10273476B2 (en) 2016-04-30 2019-04-30 University Of Iowa Research Foundation MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
US10975121B2 (en) 2017-06-24 2021-04-13 Cytogel Pharma, Llc Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
CN110698656A (zh) * 2019-10-12 2020-01-17 西安交通大学 一种低温熔融药物缓释医用高分子材料合成方法及应用
JP7519718B2 (ja) * 2020-06-23 2024-07-22 ティーエムディー ラブ カンパニー,リミテッド 温度ベース形状記憶高分子

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616799A (ja) * 1992-02-19 1994-01-25 Sagami Chem Res Center ポリエステル系多官能性マクロモノマー、ゲルおよび温度変化に応答する薬物放出制御材料
JPH0733844A (ja) * 1993-07-23 1995-02-03 Sagami Chem Res Center 脂肪族ポリエステルを主成分とするゲルおよび温度変化に応答する薬物放出制御材料
JP3772426B2 (ja) * 1995-11-28 2006-05-10 大日本インキ化学工業株式会社 発泡体及び積層体
EP1147148B1 (en) * 1998-08-31 2005-06-08 Cornell Research Foundation, Inc. Dextran-maleic acid monoesters and hydrogels based thereon
DK1168934T3 (da) * 1999-04-12 2008-05-13 Cornell Res Foundation Inc Hydrogeldannende system med hydrofobe og hydrofile komponenter
JP4565290B2 (ja) * 1999-12-01 2010-10-20 東洋紡績株式会社 高水酸基濃度を有するオキシ酸系脂肪族ポリエステルおよびオキシ酸系脂肪族ポリエステル組成物
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes

Also Published As

Publication number Publication date
CA2450123A1 (en) 2003-02-13
JP2009167418A (ja) 2009-07-30
WO2003011212A3 (en) 2003-08-07
JP2004536929A (ja) 2004-12-09
AU2002316340B2 (en) 2006-09-07
CA2450123C (en) 2013-01-29
US20030109647A1 (en) 2003-06-12
EP1411903A4 (en) 2007-01-03
US6592895B2 (en) 2003-07-15
WO2003011212A2 (en) 2003-02-13
EP1411903A2 (en) 2004-04-28

Similar Documents

Publication Publication Date Title
JP4335002B2 (ja) 生分解性多価アルコールエステル
AU2002316340A1 (en) Biodegradable polyhydric alcohol esters
AU2002248535B2 (en) Biodegradable copolymers linked to segment with a plurality of functional groups
US7138132B2 (en) Hydrogel entrapping therapeutic agent and stent with coating comprising this
JP5132000B2 (ja) 生分解性トリブロックコポリマー、その合成方法、ならびにそれから作製されるヒドロゲルおよび生体材料
JP2004536929A5 (enExample)
AU2002248535A1 (en) Biodegradable copolymers linked to segment with a plurality of functional groups
US5665831A (en) Biocompatible block copolymer
EP0927214B1 (en) Polymerizable biodegradable polymers including carbonate or dioxanone linkages
EP1168934A1 (en) Hydrogel-forming system with hydrophobic and hydrophilic components
WO1998012243A9 (en) Polymerizable biodegradable polymers including carbonate or dioxanone linkages
US8871819B2 (en) Glycerol ester active agent delivery systems and methods
US20230383143A1 (en) Method of branching polymerization induced by chain-transfer reaction
CN116496475B (zh) 用于栓塞微球的可降解交联剂、可降解栓塞微球及其制备方法和药物组合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050525

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070731

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080314

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080617

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090317

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090526

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090624

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120703

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120703

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130703

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees